-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations on clinical trials of leprosy treatment: need of novel drug combinations
Ximena Illarramendi, Maria Leide Wand del Rey de Oliveira, Anna Maria Sales, Jose Augusto da Costa Nery, Euzenir Nunes Sarno
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Peripheral T-cell lymphoma: pharmacotherapy overview
Maher Abdul-Hay, Jasmine Zain
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ranibizumab for the treatment of visual impairment due to diabetic macular edema: evidence from recent clinical trials
Laura Distefano, Anna Espax Boixadera, Charlotte Wolley-Dod, Vicente Martnez-Castillo, Jose Garcia-Arumi
Review: Clinical Trail Outcomes: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Nilotinib for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia: review of the latest clinical evidence
Massimo Breccia, Giuliana Alimena
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation
-
Bisphosphonates in the adjuvant treatment of breast cancer: rationale and clinical data
Michael Gnant
Review Article: Clinical Investigation